Qumis | $2,200,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Certified by Founder
Lodge
Unlearn.AI
start up
United States
- San Francisco, California
- 19/04/2022
- Series B
- $50,000,000
Accelerating clinical trials with AI.
- Industry Biotechnology
- Website https://www.unlearn.ai/
- LinkedIn https://www.linkedin.com/company/unlearn-ai/
Related People
Charles FisherFounder
United States -
San Francisco Bay Area
Solving the most challenging problems in biology and healthcare using statistical physics and machine learning.
Contacting me:
I am not open to full-time employment opportunities and will not respond to related messages.
LinkedIn
https://www.linkedin.com/in/drckf/
Gravity | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)